The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 288 participants.

Also called NCT05231694

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 288 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05231694
Other papers using this trial's data
  • Specific mode acupoint electrical stimulation combined with NGF for neurological recovery in ischemic stroke convalescence: A randomized controlled study BMC medicine, 2026-07-20 DOI, PubMed 42477731, PMC13670477 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05231694. Randomized; triple masking; primary purpose treatment. Start 2022-04-01 (actual); primary completion 2025-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
Intervention (Drug)
Nerver growth factor (NGF) injection
Intervention (Drug)
Placebo injection
Intervention (Device)
EA intervention
Intervention (Device)
sham EA intervention
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University (class: other)
Collaborator
Ningbo No.2 Hospital (class: other)
Collaborator
second people hospital of lishui (class: not stated)

Record details

Record id
cardio:ct-nct05231694
Content hash
86ccfc38a6cdee47a4f77644d51d2f7285eb35c7bb204621a6842d303c9ef32d